Navigation Links
Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials
Date:5/16/2013

tance and increasing their potency when bacteria become dormant or form a biofilm. 

Lakewood-Amedex's Vice President, Product Development, Paul DiTullio , commented "The recent studies using Nu-3 provide further confirmation of the major advantages offered by the bisphosphocin class for the treatment of bacterial and fungal infections and their potential to address several major healthcare problems."

The Company is fast tracking the development of a topical bisphosphocin formulation specifically because its rapid bactericidal activity makes it an excellent therapeutic candidate to address several unmet medical needs for clinical indications such as acute bacterial skin infection, infected diabetic foot ulcer, ophthalmic infections, and fungal infections such as onychomycosis.  In addition, bisphosphocins exhibit an extremely broad spectrum of activity that is critical when addressing clinical indications where the infection may be polymicrobial, or with eye infections where there is no time to identify the infecting organism.  The compounds possess an excellent safety profile and are well tolerated in vivo due to their highly specific mechanism of action that exploits a critical difference between the prokaryotic membranes of bacteria/fungi and the eukaryotic membranes of mammals, including humans. 

Lakewood-Amedex expects to make additional major announcements regarding the utility of the bisphosphocin family of broad-spectrum antimicrobials in the coming weeks and is actively seeking partnering opportunities for major indications using these products.

About Lakewood-Amedex, Inc.

Lakewood-Amedex is a privately held biopharmaceutical company developing a broad portfolio of anti-infective products, including first-in-class anti-bacterial compounds, orally available nanoRNA therapeutics for acute and chronic diseases such as arthritis, inflammation, cancer, influenza, and he
'/>"/>

SOURCE Lakewood-Amedex Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Physician-Patient Alliance for Health & Safety Announces Four Essentials for Safety for Patients Receiving Opioids
2. DebMed Announces US Patent
3. Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients
4. Active Life Announces $500K Follow On Series A Investment - Tech Coast Angels Re-up
5. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
6. TSI Announces 2013 Respiratory Protection Roadshow Training Dates and Locations
7. Vasomedical Announces Financial Results for the First Quarter of 2013
8. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
9. Pharmagen Announces First Quarter 2013 Results
10. BioDrain Announces First Quarter 2013 Results
11. International Isotopes Inc. Announces First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014  Kindred Hospital Houston Northwest, with Wound ... of its new outpatient wound healing center.  The ... with chronic, hard to heal wounds. Chronic wounds ... amputation, lower leg wounds related to blood flow ... traumatic injury wounds which are complex and demonstrate ...
(Date:7/11/2014)...  Australian drug delivery company, Phosphagenics Limited (ASX: POH; ... million via a placement of A$16.3 million to institutional ... Asia and Australia ... plan (SPP) to be offered to existing shareholders.  The ... tranches. "This capital raising positions us strongly ...
(Date:7/11/2014)... 2014 On Thursday, July ... the Dow Jones Industrial Average finished the day 0.42% lower ... 0.41%. The losses were broad based as eight out of ... Health Care Sector Index ended the day at 711.88, down ... one month. Investor-Edge has initiated coverage on the following equities: ...
Breaking Medicine Technology:Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4
... NEW YORK, Sept. 22 Amgen and Pfizer today ... Everyday Style and Psoriasis™," an online resource, providing a ... Hosted by Tim Gunn, mentor to the designers on ... Claiborne, Inc. and dermatologist Susan C. Taylor, M.D., the ...
... of Surgery Case Reports -- OXFORD, England, September 22, 2010 ... ... ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
Cached Medicine Technology:Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn 2Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn 3Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn 4Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn 5Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn 6Elsevier Launches International Journal of Surgery Case Reports 2Elsevier Launches International Journal of Surgery Case Reports 3Elsevier Launches International Journal of Surgery Case Reports 4Elsevier Launches International Journal of Surgery Case Reports 5Elsevier Launches International Journal of Surgery Case Reports 6Elsevier Launches International Journal of Surgery Case Reports 7Elsevier Launches International Journal of Surgery Case Reports 8Elsevier Launches International Journal of Surgery Case Reports 9
(Date:7/11/2014)... York, NY (PRWEB) July 11, 2014 ... during the five years to 2014 on the heels ... of 2010 prompted farmers to dedicate a larger share ... ethanol production. More specifically, the regulations required the mixing ... rapidly expanding biofuel production in the United States created ...
(Date:7/11/2014)... surgery to repair damage to the anterior cruciate ligament (ACL) ... -- could increase a young athlete,s risk for further injuries, ... patients, aged 8 to 16, who had ACL reconstruction surgery. ... after their injury, 37 had surgery six to 12 weeks ... after their injury. The youngsters who had surgery later ...
(Date:7/11/2014)... Steven Reinberg HealthDay Reporter ... potential vaccine to protect children from the worldwide scourge of ... children. While the vaccine only prevented dengue fever in ... series of three shots, it protected more than 88 percent ... fever can lead to hospitalization, and sometimes death. "This ...
(Date:7/11/2014)... July 11, 2014 (HealthDay News) -- Prostate cancer patients ... receive less effective treatment and die sooner if they ... analyzed data from more than 41,200 American men who ... 2007. They followed them through 2009. Nearly 1,900 of ... two years before their prostate cancer was discovered. ...
(Date:7/11/2014)... Down is a reliable source for cheap Luke Bryan tickets ... years Luke Bryan has been honored by almost every major association ... award shows, but each summer, he hits the road on what ... and this summer is more of the same. When it comes ... success that is currently entitled to Luke Bryan. The native of ...
Breaking Medicine News(10 mins):Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3Health News:Delaying Kid's Knee Surgery Could Be a Bad Play, Study Finds 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 2Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 3
... , FORT MYERS, Fla., Dec. 4 NeoGenomics, Inc. ... Jones has been appointed Executive Vice President, Finance and that George ... Mr. Cardoza will be responsible for managing all internal financial affairs ... focus on developing strategic initiatives on behalf of NeoGenomics as well ...
... CITY, Mo., Dec. 4 Farmers Insurance Missouri State Executive Director ... CEO and creator of a children,s fire safety program sponsored by ... a children,s fire safety day at the Missouri Capitol December 9. ... for fire safety comes following a tragic fire that took the ...
... 2009 New findings by UT Southwestern researchers suggest ... might also help slow the destruction of insulin-producing cells ... In type 1 diabetes, formerly known as ... which produce insulin, are destroyed by an autoimmune process. ...
... personality, study finds , FRIDAY, Dec. 4 (HealthDay News) -- ... Facebook, reveal the real you? The odds are good that ... tend to express their true selves instead of idealized identities. ... widely held assumption is that people are using their profiles ...
... ... signed exclusive agreements in 2009 with USA IDN Health Systems and hospitals valued at $22.4 ... the end of 2009. , ... Seattle, WA (PRWEB) December 4, 2009 -- PHACTS, LLC, a leader in Pharmacy Inventory Management ...
... , ORLANDO, Fla., Dec. 4 , ,What: ... health benefits provider, is introducing Dancetown, ... video game at its Kissimmee Guidance Center on Tues., ... event, which is, free and open ...
Cached Medicine News:Health News:NeoGenomics Announces Executive Appointments 2Health News:Missouri Safety Day at the Capitol 2Health News:FDA-approved drug may slow beta cell destruction in type 1 diabetes patients 2Health News:Online Identities Likely to Match Reality 2Health News:PHACTS Receives $22.4 Million in New Business Commitments 2Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Inoculum Broth with Calcium Chloride and Phytone....
...
Medicine Products: